Sims Karen

Insider profile

Performance

Overall performance
2.4

Performance over holding periods
4.2
30 days 90 days 120 days
Average return -5% 8.2% 15.1%
Success rate 1% 68% 82%
Transactions
4 75% Buy
34 71% Buy
47 69% Buy
Performance for realised trades
4.4
Average return 12%
Success rate 73%
Average holding period 220
Transactions 28
Sims Karen's trades of Arbutus Biopharma Corp's stock


Loading...
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
369.97
Quantity 95,230
Value £4,379,931
Transaction date
Sale
Price
2.88
Quantity 8,259
Value £23,782
Transaction date
Purchase
Price
2.84
Quantity 28
Value £79
Transaction date
Purchase
Price
2.50
Quantity 60
Value £150
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2025-02-05 2025-02-04 PlS Planned sale
52,230 -20.6%
468.25
US$681,250
52,230 -20.6% 468.25 US$681,250
2025-02-04 2025-02-04 PrS Proposed sale
74,508
111.17
US$2,541,873
74,508 111.17 US$2,541,873
2024-07-03 2024-07-01 B Purchase
95,230
369.97
£4,379,931
95,230 369.97 £4,379,931
2024-02-05 2024-02-02 PlS Planned sale
4,358 -3.4%
2.31
US$10,078
4,358 -3.4% 2.31 US$10,078
2023-12-11 2023-12-08 S Sale
8,259
2.88
£23,782
8,259 2.88 £23,782
2023-11-29 2023-11-27 B Purchase
28
2.84
£79
28 2.84 £79
2023-06-28 2023-06-26 B Purchase
60
2.50
£150
60 2.50 £150